Petco Health and Wellness Co Inc - Class A
Q1 2026 Earnings
Market Reaction
S&P 500 over the same 30 days: +4.45%.
Did WOOF Beat Earnings? Q1 2026 Results
Petco Health and Wellness posted a mixed but broadly encouraging first quarter for fiscal 2025, with results coming in ahead of the company's own guidance even as Wall Street had hoped for more, reporting an EPS of -$0.04 and net sales of $1.49 billion, a 2.3% year-over-year decline that reflected ongoing softness in product revenue. The more compelling story was margin discipline: gross profit margin expanded roughly 30 basis points to 38.2%, SG&A expenses fell 7% to $553.61 million, and operating income swung to a gain of $16.36 million from a $16.78 million loss a year earlier, with Adjusted EBITDA climbing to $89.45 million from $75.64 million. Services revenue, which includes veterinary, grooming, and training, rose 1% to $251.51 million, underscoring how Petco's shift toward recurring health-and-wellness offerings is cushioning the top-line pressure that's affecting <a href="https://247wallst.com/investing/2025/06/04/bark-inc-bark-earnings-live-turnaround-in-sight-but-stock-under-scrutiny/">broader pet industry players</a> as well. Looking ahead, the company reaffirmed full-year guidance for Adjusted EBITDA of $375 million to $390 million, with Q2 Adjusted EBITDA expected between $92 million and $94 million, assuming current tariff levels hold through year-end.
- Gross profit margin expansion of approximately 30 basis points to 38.2%
- SG&A expenses reduced 7% year over year
- Operating income improved $33.1 million year over year
- Adjusted EBITDA margin expanded to 6.0% from 4.9%
- Services and other revenue grew 1% year over year
- Execution of operational reset strategy to strengthen retail fundamentals
“We are pleased to deliver first quarter earnings results ahead of our guidance and to reaffirm our outlook for fiscal 2025 which now incorporates the impact of tariffs. This performance is a testament to the execution of our nearly 30,000 team members and the resilience of the category in which we operate.”
Petco Health & Wellness CEO, on the earnings call
Forward Guidance & Outlook
Petco reaffirmed its full-year fiscal 2025 outlook: net sales expected down low single digits year over year, Adjusted EBITDA of $375 million to $390 million, net interest expense of approximately $130 million, capital expenditures of $125 million to $130 million, and depreciation & amortization of approximately $200 million. For Q2 2025, the company guided to net sales down low single digits year over year and Adjusted EBITDA of $92 million to $94 million. Guidance assumes that current tariffs on imports into the U.S. from China and other countries as of June 5, 2025 stay at current levels and do not increase for the remainder of the year.
WOOF YoY Financials
WOOF Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.